Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Preclinical CRO market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 8.0% during the forecast period.
This report presents the market size and development trends by detailing the Preclinical CRO market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Preclinical CRO market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Preclinical CRO industry and will help you to build a panoramic view of the industrial development.
Preclinical CRO Market, By Type:
Bioanalysis and DMPK Studies
Toxicology Testing
Other Preclinical Services
Preclinical CRO Market, By Application:
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
Some of the leading players are as follows:
PRA Health Science, Inc
Medpace, Inc.
Laboratory Corporation of America
Charles River Laboratories International, Inc.
Pharmaceutical Product Development, LLC.
Paraxel International Corporation
Envigo, Eurofins Scientific.
Wuxi AppTec
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Preclinical CRO Market: Technology Type Analysis
-
4.1 Preclinical CRO Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Preclinical CRO Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Bioanalysis and DMPK Studies
4.3.2 Toxicology Testing
4.3.3 Other Preclinical Services
5 Preclinical CRO Market: Product Analysis
-
5.1 Preclinical CRO Product Market Share Analysis, 2018 & 2026
-
5.2 Preclinical CRO Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Preclinical CRO Market: Application Analysis
-
6.1 Preclinical CRO Application Market Share Analysis, 2018 & 2026
-
6.2 Preclinical CRO Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Biopharmaceutical Companies
6.3.2 Government and Academic Institutes
6.3.3 Medical Device Companies
7 Preclinical CRO Market: Regional Analysis
-
7.1 Preclinical CRO Regional Market Share Analysis, 2018 & 2026
-
7.2 Preclinical CRO Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 PRA Health Science, Inc
9.1.1 PRA Health Science, Inc Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Medpace, Inc.
9.2.1 Medpace, Inc. Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Laboratory Corporation of America
9.3.1 Laboratory Corporation of America Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Charles River Laboratories International, Inc.
9.4.1 Charles River Laboratories International, Inc. Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Pharmaceutical Product Development, LLC.
9.5.1 Pharmaceutical Product Development, LLC. Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Paraxel International Corporation
9.6.1 Paraxel International Corporation Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Envigo, Eurofins Scientific.
9.7.1 Envigo, Eurofins Scientific. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Wuxi AppTec
9.8.1 Wuxi AppTec Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
The List of Tables and Figures (Totals 90 Figures and 127 Tables)
Figure Bioanalysis and DMPK Studies Preclinical CRO market, 2015 - 2026 (USD Million)
Figure Toxicology Testing Preclinical CRO market, 2015 - 2026 (USD Million)
Figure Other Preclinical Services Preclinical CRO market, 2015 - 2026 (USD Million)
Figure Biopharmaceutical Companies market, 2015 - 2026 (USD Million)
Figure Government and Academic Institutes market, 2015 - 2026 (USD Million)
Figure Medical Device Companies market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Preclinical CRO market, by country, 2015 - 2026 (USD Million)
-
Table North America Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table North America Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table North America Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Canada Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Canada Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Europe Preclinical CRO market, by country, 2015 - 2026 (USD Million)
-
Table Europe Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Europe Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Europe Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Germany Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Germany Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table France Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table France Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Italy Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Italy Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Spain Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Spain Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Preclinical CRO market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table China Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table China Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Japan Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Japan Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table India Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table India Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Preclinical CRO market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table MEA Preclinical CRO market, by country, 2015 - 2026 (USD Million)
-
Table MEA Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table MEA Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table MEA Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Preclinical CRO market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Preclinical CRO market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Preclinical CRO market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table PRA Health Science, Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medpace, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Laboratory Corporation of America Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Charles River Laboratories International, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pharmaceutical Product Development, LLC. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Paraxel International Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Envigo, Eurofins Scientific. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Wuxi AppTec Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
